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Clinical Effect of a New 1-4-Dihydropyridine Derivative, 
YC-93, in Patients with Cerebrovascular Diseases 
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TETSUAKI TERAURA 
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A new derivative of 1,4-dihydropyridine, YC 93, has been proved to be a potent 
vasodilator in various kinds of exp2rimental animals as well as in healthy volunteers. 
Sixty mg of YC 93 in three divided dosages was given to 32 patients with cerebro-
vascular diseases for 4 weeks, and its clinical effects were examined. This pilot 
study has proved that YC-93 is a valuable therapeutic agent in improving chronic 
subjective complaints clue to cercbrovascular ischemia, with minimal side effects. 
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脳血管障害例IL対する 1,4-Dihydropyridine誘導体 YC-93の臨床使用経験 401 
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2, 6 dimethyl -4-(3-nitr.:iphenyl)-1, 4 dihydropyridine-3, 5-di-
carboxylic acid 3-{2-(N-benzyl-N-methylamino)}-ethyl ester 
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